This model suits patients who prioritize rapid initiation and steady virtual followup
By regulating hunger signals and stabilizing blood sugar levels, it helps patients naturally reduce calorie intake without constant cravings or feelings of deprivationmaking gradual, consistent, and sustainable weight loss achievable
Por otro lado, hay que destacar que tras retirar el tratamiento se produce un empeoramiento de los componentes de la DLP aterognica, observndose principalmente un aumento de c-VLDL y TG37,39
In my job, I have to stand up and present to many people
For clinicians and patients, the practical timeline matters: CagriSema is closer to potential approval (phase 3 complete), while amycretin's phase 3 is planned for 2026